Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-29

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

intratympanic steroid injection bell's palsy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy

NCT01686464

Bell's Palsy

COMPLETED NA

Ultrasound-Guided Corticosteroid and Bupivacaine for Facial Nerve Function and Thickness in Bell's Palsy

NCT06955455

Bell's Palsy

COMPLETED NA

Ultrasound-Guided Stellate Ganglion Block With Botulinum

NCT05099835

Change From Baseline House-Brackmann

COMPLETED NA

Ancillary Procedures in Patients of Refractory Facial Palsy Patients Selection and Evaluation of the Outcomes

NCT04237961

Facial Palsy

UNKNOWN NA

Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis

NCT03048383

Facial Nerve Injuries Facial Paresis Associated With Facial Nerve Dysfunction Facial Asymmetry +1 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Role of oral steroid alone versus oral steroid plus intratympanic steroid injection in Bell's palsy

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bell Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral steroids

Oral steroids only

Group Type ACTIVE_COMPARATOR

Corticosteroid

Intervention Type DRUG

Oral steroids plus intratympanic injection

Oral steroids plus intratympanic injections

Group Type ACTIVE_COMPARATOR

Corticosteroid

Intervention Type DRUG

Oral steroids plus intratympanic injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Corticosteroid

Oral steroids plus intratympanic injection

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mean Aged 18 years or more.

* Acute unilateral facial palsy without skin lesions which developed within a 72-hour period and is present for 21 days or less.
* Moderate to severe facial palsy \[House-Brackmann grade IV or greater\]

Exclusion Criteria

* Another cause of facial nerve paralysis that is not idiopathic.

* Otologic disease including otitis media, temporal bone fracture, a previous history of facial nerve palsy in either side, history of otologic surgery, and suspected Ramsay Hunt syndrome.
* Systemic disease including history of tuberculosis, history of head and neck cancer, other neurological disorders, recent use of ototoxic medications, liver or renal dysfunction, and other illnesses that would contraindicate the use of high-dose steroid therapy.
* Pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No